[HTML][HTML] “Should I Inhale?”—Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative …

J Sinclair, S Armour, JA Akowuah, A Proudfoot… - International Journal of …, 2022 - mdpi.com
Objective: This study sought to investigate the perceptions, barriers, and drivers associated
with medicinal cannabis use among Australian women with primary dysmenorrhea. A …

Cannabis use for endometriosis: clinical and legal challenges in Australia and New Zealand

J Sinclair, Y Toufaili, S Gock, AG Pegorer… - Cannabis and …, 2022 - liebertpub.com
Introduction: Endometriosis is a difficult to manage condition associated with a significant
disease burden. High levels of illicit cannabis use for therapeutic purposes have been …

Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey

M Armour, J Sinclair, G Noller, J Girling… - Journal of women's …, 2021 - liebertpub.com
Background: Endometriosis affects around 10% of women worldwide. Many women with
endometriosis struggle with finding adequate pain management, and data from other …

[HTML][HTML] Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?

A Seifalian, J Kenyon, V Khullar - International Journal of Molecular …, 2022 - mdpi.com
Dysmenorrhoea effects up to 90% of women of reproductive age, with medical management
options including over-the-counter analgesia or hormonal contraception. There has been a …

[PDF][PDF] New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users

MJ Pledger, G Martin, J Cumming - The New Zealand Medical …, 2016 - researchgate.net
ABSTRACT AIM: To explore the characteristics of medicinal and non-medicinal cannabis
users, and the conditions that were treated with cannabis. METHODS: The data comes from …

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis

CM Hallinan, JM Gunn, YA Bonomo - BMJ open, 2021 - bmjopen.bmj.com
Objective We sought to explore physician perspectives on the prescribing of cannabinoids to
patients to gain a deeper understanding of the issues faced by prescriber and public health …

[HTML][HTML] Survey of Australians using cannabis for medical purposes

W Swift, P Gates, P Dillon - Harm Reduction Journal, 2005 - Springer
Abstract Background The New South Wales State Government recently proposed a trial of
the medical use of cannabis. Australians who currently use cannabis medicinally do so …

So near yet so far: why won't the UK prescribe medical cannabis?

D Nutt, S Bazire, LD Phillips, AK Schlag - BMJ open, 2020 - bmjopen.bmj.com
Although cannabis-based products for medicinal use are now legal in the UK, it is still
challenging for patients to gain access, and only very few National Health Service …

Barriers and facilitators to prescribing medicinal cannabis in New Zealand

V Withanarachchie, M Rychert… - Journal of Primary Health …, 2023 - CSIRO Publishing
Introduction The New Zealand Medicinal Cannabis Scheme (NZMCS) was established in
April 2020 with the aim of expanding access to quality controlled medicinal cannabis …

Medicinal cannabis in Australia, 2016: the cannabis as medicine survey (CAMS‐16)

N Lintzeris, J Driels, N Elias, JC Arnold… - Medical Journal of …, 2018 - Wiley Online Library
Objective: To explore patterns of cannabis use for medical purposes in Australia
immediately prior to the 2016 legislation for frameworks for medical cannabis use. Design …